Amylon-LLC---logo

Amylon LLC

Amylon_ LLC, (spun-off a subsidiary of Aphios Corporation) is developing APH-1104, for mild to moderate Alzheimers disease and other CNS disorders such as Downs syndrome and glaucoma.

In 2010, Aphios received a 3-year, NIH Fast Track SBIR grant to develop an oral formulation of APH-0703. This research has led to the discovery of a more potent analog, APH-1104, which Amylon LLC plans to develop for Alzheimers disease.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://amylon.com
Founded2017
Disease Focus
Development StageDiscovery
STOCK CODENon Listed
Address
Zernikedreef 9, 2333CK
Leiden
Netherlands
Email
Contact Number
+1 781-932-6933

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]